ghvexb | 20876

UBA1 mutations (VEXAS syndrome) (blood)

Material
Blood EDTA
EDTA tube, purple (6)
Note

There is a possibility of excess information occurring with this analysis. This will be communicated, unless it is noted otherwise when placing the order. Since in rare cases there may also be indications of hereditary changes, the HGTA (Federal Act on Human Genetic Testing) provides for the patient to be informed accordingly (see www.viollier.ch/en/SGMG_consent).

Min. quantity 1 mL
Stability 1 day / 18-25°C; 4 days / 2-8°C
Duration 5 days
Frequency 2 x per week
Method Next Generation Sequencing
Price CHF 0.00
Tariff 0.00 TP

Team of consultants

PD, MD Giuseppe Colucci FMH internal medicine, hematology, FAMH Specialist in laboratory medicine
FMH internal medicine, hematology, FAMH Specialist in laboratory medicine T +41 61 486 14 57
PhD Christian Kalberer FAMH Specialist in laboratory medicine, main field hematology
FAMH Specialist in laboratory medicine, main field hematology T +41 61 486 15 14
MD Kaoutar Hamouda General Medicine, Candidate FAMH Specialist in laboratory medicine, main field medical hematology
General Medicine, Candidate FAMH Specialist in laboratory medicine, main field medical hematology T +41 61 486 15 21
MD FMH hematology, FAMH Specialist in laboratory medicine Maurice Redondo Head of Routine laboratories
Head of Routine laboratories T +41 61 486 11 11
MD Boris E. Schleiffenbaum FMH internal medicine, hematology, FAMH Specialist in laboratory medicine, main field hematology
FMH internal medicine, hematology, FAMH Specialist in laboratory medicine, main field hematology T +41 76 422 83 00